Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled salbutamol and ipratropium bromide for transient tachypnea of the newborn
PACTR202506603201609Completed
- Sponsor
- Suez Canal University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ipratropium bromide and salbutamol in transient tachypnea of the newborn (TTN) (3 arms), sponsored by Suez Canal University. Started Oct 2022; status: completed.
02
Drugs
ipratropium bromidesalbutamol
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on PACTR202506603201609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506603201609.